Recent developments
Regional capacity moves
IFF expanded Latin American capabilities, converting its Arroyito, Argentina site into the first full fermentation-based enzyme production hub in Latin America and opening a household care application laboratory in Brazil to tailor laundry and dishwashing formulations for regional conditions, serving home and personal care markets.
Portfolio realignment
Portfolio reshaping continued: SEQENS divested its Limoges Botanical Actives and IVD units to Solabia to refocus on core Pharmaceutical Solutions and Specialty Ingredients. BASF completed the sale of its optical brightening agent business, including Monthey production, to Catexel (ICIG), with about 80 employees transferring.
Earnings and targets
Symrise reported €4,929 million revenues, 2.8% organic growth, a 21.9% adjusted EBITDA, and advanced its ONE SYM Transformation, guiding 2026 organic growth of 2–4%. Clariant delivered a 17.8% 2025 EBITDA margin before exceptionals and CHF 50 million savings, guiding flat 2026 local-currency sales and about 18% margin.
Sustainable ingredients R&D
Toray introduced bio-based polyamide 4 for cosmetics microplastic replacement, using biomass-derived 2‑pyrrolidone with marine biodegradability. Scale-up is planned by FY March 2029; the route also enables bio-based 2‑pyrrolidone supply for NMP and NVP used across electronics, engineering plastics, and pharmaceuticals.